In conclusion, ginsenoside Rg3 protects against diabetic cardiomyopathy through modulating glucose and lipid metabolism by directly binding to PPAR-γ and activation of the adiponectin pathway. The gene discussed is PPARG; the disease is diabetic cardiomyopathy.